T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$7.49B |
| 2 |
Micron Technology
MU
|
+$6.62B |
| 3 |
Lam Research
LRCX
|
+$3.45B |
| 4 |
Applied Materials
AMAT
|
+$3.03B |
| 5 |
Advanced Micro Devices
AMD
|
+$2.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$12.1B |
| 2 |
Apple
AAPL
|
+$11.6B |
| 3 |
Amazon
AMZN
|
+$3.54B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$3.07B |
| 5 |
Keysight
KEYS
|
+$1.82B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.73% |
| 2 | Healthcare | 11.3% |
| 3 | Financials | 10.32% |
| 4 | Communication Services | 9.66% |
| 5 | Industrials | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
SBA Communications
SBAC
$17.3B
| $48.5M | ﹤0.01% |
274,868
+119,019
| +76% | +$24.5M |
|
902
Stride
LRN
$3.19B
| $48.3M | ﹤0.01% |
560,228
+205,190
| +58% | +$18.9M |
|
903
Xometry
XMTR
$5.9B
| $48.3M | ﹤0.01% |
500,548
+358,314
| +252% | +$25.6M |
|
904
Kadant
KAI
$3.19B
| $47.9M | ﹤0.01% |
152,296
-22,550
| -13% | -$7.03M |
|
905
Crocs
CROX
$5.87B
| $47.8M | ﹤0.01% |
395,983
+118,922
| +43% | +$13M |
|
906
Haemonetics
HAE
$4.81B
| $47.8M | ﹤0.01% |
636,797
+216,522
| +52% | +$13.9M |
|
|
NAVN
907
Navan Inc
NAVN
$5.2B
| $47.5M | ﹤0.01% |
2,074,910
+1,041,946
| +101% | +$19.1M |
|
908
IDEX
IEX
$17B
| $47.1M | ﹤0.01% |
207,428
+39,207
| +23% | +$8.29M |
|
909
Axogen
AXGN
$2.55B
| $47M | ﹤0.01% |
1,018,042
+967,257
| +1,905% | +$39M |
|
910
Planet Labs
PL
$6.11B
| $46.9M | ﹤0.01% |
1,416,999
+565,669
| +66% | +$20.9M |
|
911
Workiva
WK
$3.71B
| $46.9M | ﹤0.01% |
966,637
+427,595
| +79% | +$22M |
|
912
Incyte
INCY
$25.3B
| $46.4M | ﹤0.01% |
409,514
-342,342
| -46% | -$34M |
|
913
Pinnacle Financial Partners Inc
PNFP
$14.1B
| $46.3M | ﹤0.01% |
459,232
+127,765
| +39% | +$12.3M |
|
914
Fluor
FLR
$6.58B
| $46.3M | ﹤0.01% |
883,608
+549,005
| +164% | +$26.9M |
|
915
Futu Holdings
FUTU
$15.7B
| $46M | ﹤0.01% |
490,476
-715,777
| -59% | -$91.7M |
|
916
Structure Therapeutics
GPCR
$2.5B
| $45.4M | ﹤0.01% |
845,532
-1,155,164
| -58% | -$51.1M |
|
917
Kroger
KR
$35.3B
| $45.4M | ﹤0.01% |
816,757
-10,714
| -1% | -$699K |
|
918
Ultragenyx Pharmaceutical
RARE
$1.42B
| $45.3M | ﹤0.01% |
1,356,501
+552,392
| +69% | +$13.7M |
|
|
MBX
919
MBX Biosciences
MBX
$2.77B
| $45M | ﹤0.01% |
814,807
-214,200
| -21% | -$7.48M |
|
920
Extra Space Storage
EXR
$27.8B
| $44.9M | ﹤0.01% |
308,951
+4,986
| +2% | +$713K |
|
|
FDXF
921
FedEx Freight
FDXF
$16.8B
| $44.9M | ﹤0.01% |
+297,140
| New | +$48.7M |
|
922
Raymond James Financial
RJF
$31B
| $44.5M | ﹤0.01% |
292,408
+7,379
| +3% | +$1.12M |
|
923
Zebra Technologies
ZBRA
$17.6B
| $44.2M | ﹤0.01% |
167,971
+21,004
| +14% | +$4.94M |
|
924
NiSource
NI
$18.8B
| $44M | ﹤0.01% |
926,115
+64,549
| +7% | +$3.05M |
|
925
Magnolia Oil & Gas
MGY
$6.38B
| $43.8M | ﹤0.01% |
1,713,122
+1,468,803
| +601% | +$41.9M |
|
Similar funds
T. Rowe Price Associates's Q2 2026 Portfolio in Review
As of Q2 2026, T. Rowe Price Associates held 3,356 positions worth $999B, up 16% from $865B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q2 2026 filing shows 224 new, 2,237 increased, 645 reduced and 116 closed positions. Its largest new stake was SpaceX: 10,709,016 shares worth $1.83B. The largest sale was Microsoft, an estimated $12.1B.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 34% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2026 buy was SpaceX: 10,709,016 shares worth $1.83B.
- T. Rowe Price Associates added most to Alphabet (Google) Class A in Q2 2026, an estimated $7.49B increase.
- T. Rowe Price Associates's biggest Q2 2026 reduction was Microsoft, cutting an estimated $12.1B.
- T. Rowe Price Associates fully exited Sibanye-Stillwater in Q2 2026, selling an estimated $40.4M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $999B portfolio in Q2 2026.
- T. Rowe Price Associates opened 224 new positions and closed 116 in Q2 2026.
- T. Rowe Price Associates's portfolio value rose 16% quarter-over-quarter to $999B.
Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.